Prenetics Global Limited - Class A Ordinary Share (PRE)
Frequently Asked Questions About Prenetics Global Limited - Class A Ordinary Share (PRE)
Are Prenetics' tests clinically validated?
Yes, Prenetics' tests are clinically validated to ensure the accuracy and reliability of the results. The company adheres to rigorous clinical validation processes, leveraging scientific research and data to support the claims made in its genetic testing reports.
How does Prenetics contribute to public health?
Prenetics contributes to public health through its extensive testing services, including COVID-19 testing and preventive health screenings. By providing access to vital health information, the company helps individuals take informed actions to safeguard their health and prevent disease transmission.
How does Prenetics engage with customers?
Prenetics engages with customers through its user-friendly platforms that provide access to test results and health insights. Additionally, the company offers customer support and educational resources to help clients fully understand the implications of their genetic testing outcomes.
How does Prenetics ensure data privacy?
Prenetics prioritizes data privacy by implementing strict security measures to protect personal health information. The company complies with relevant regulations, such as HIPAA and GDPR, ensuring that customers' genetic and health data remain confidential and secure.
Is Prenetics publicly traded?
Yes, Prenetics Global Limited is publicly traded on the Nasdaq under the ticker symbol PRE. The company went public through a merger with a special purpose acquisition company (SPAC) in 2021, facilitating its entry into the public equity markets.
What can investors expect from Prenetics in the future?
Investors can expect Prenetics to continue its growth trajectory by expanding its product offerings, enhancing technological capabilities, and entering new markets. The company aims to leverage its strengths in biotechnology to lead innovations in personalized healthcare and diagnostics.
What certifications does Prenetics hold?
Prenetics holds various certifications and accreditations that validate its testing processes and laboratory operations. These include ISO certifications and CLIA certifications, ensuring that the company meets the highest standards of quality and accuracy in its testing services.
What does Prenetics Global Limited do?
Prenetics Global Limited is a biotechnology company that offers a range of diagnostic and genetic testing services. The company leverages cutting-edge technology and innovative solutions to empower individuals and healthcare providers with actionable insights related to health and wellness, disease prevention, and genetic predisposition.
What impact did COVID-19 have on Prenetics?
The COVID-19 pandemic significantly impacted Prenetics by increasing demand for testing services. The company adapted swiftly by offering COVID-19 testing solutions and partnered with various entities to facilitate large-scale testing, showcasing its ability to respond to public health crises effectively.
What is Prenetics' vision for the future?
Prenetics' vision for the future is to be at the forefront of personalized healthcare by continuously innovating and expanding its suite of services. The company aims to make genetic testing accessible to a broader audience, ultimately enhancing individual health outcomes and transforming global health management.
What is the company's mission?
Prenetics' mission is to empower individuals to understand their health better and take proactive steps toward improved wellbeing. The company strives to provide innovative genetic testing solutions that promote personalized health insights and enable informed healthcare decisions.
What is the role of genetic testing in Prenetics' offerings?
Genetic testing is central to Prenetics' offerings, as it provides insights into individuals' health risks, carrier status, and wellness potential. These genetic reports enable customers to make informed lifestyle choices and participate in preventive health measures.
What is the significance of Prenetics' technology?
Prenetics’ technology is significant because it utilizes advanced genomic sequencing and artificial intelligence to provide accurate and reliable health information. This technology helps bridge the gap between genetic data and practical health management, enhancing decision-making for individuals and healthcare providers alike.
What markets does Prenetics operate in?
Prenetics operates primarily in the healthcare and biotechnology sectors, with a focus on markets in Asia and North America. These regions are critical for the company as they represent significant demand for genetic testing and personalized healthcare solutions.
What partnerships does Prenetics have?
Prenetics has established various strategic partnerships with healthcare providers, universities, and research institutions to expand its reach and enhance its offerings. These collaborations aim to promote research and development in precision medicine and genetic testing technologies.
What products and services does Prenetics offer?
Prenetics offers a variety of products and services, including genetic testing for hereditary health risks, carrier testing, and wellness information. Their services also extend to COVID-19 testing, allowing individuals and organizations to obtain reliable testing solutions during the pandemic.
When was Prenetics founded?
Prenetics was founded in 2014. Since its inception, the company has focused on advancing personalized healthcare solutions, utilizing genetic testing to deliver critical health information to consumers and healthcare professionals.
Where is Prenetics headquartered?
Prenetics is headquartered in Hong Kong, with additional operations across various locations including the United States and the United Kingdom. This global presence enables Prenetics to serve a diverse clientele and meet the growing demand for innovative health solutions.
Who are Prenetics' main competitors?
Prenetics faces competition from several key players in the genetic testing and diagnostics market, including 23andMe, Ancestry, and companies like LabCorp and Quest Diagnostics that offer broad testing services. The competitive landscape is continually evolving as technology and consumer demands change.
What is the current price of Prenetics Global Limited - Class A Ordinary Share?
The current price of Prenetics Global Limited - Class A Ordinary Share is 7.010
When was Prenetics Global Limited - Class A Ordinary Share last traded?
The last trade of Prenetics Global Limited - Class A Ordinary Share was at 4:00 pm EDT on June 13th, 2025
What is the market capitalization of Prenetics Global Limited - Class A Ordinary Share?
The market capitalization of Prenetics Global Limited - Class A Ordinary Share is 701.00M
How many shares of Prenetics Global Limited - Class A Ordinary Share are outstanding?
Prenetics Global Limited - Class A Ordinary Share has 100.00M shares outstanding.